Neuropeptide Y and sleep
- PMID: 20122859
- DOI: 10.1016/j.smrv.2009.09.001
Neuropeptide Y and sleep
Abstract
Neuropeptide Y (NPY), a 36-amino-acid peptide from the pancreatic polypeptide family, is one of the more abundant peptides in the central nervous system. It acts as a neurohormone and as a neuromodulator. NPY is widely distributed in the brain, particularly the hypothalamus, the amygdala, the locus coeruleus and the cerebral cortex. At least six NPY receptors subtypes have been identified. NPY is involved in the regulation of several physiological functions such as food intake, hormonal release, circadian rhythms, cardiovascular disease, thermoregulation, stress response, anxiety and sleep. Sleep promoting effects of NPY as well as wakefulness effects of NPY were found in animals, depending on the site of injection as well as on the functional state of the structure. In humans, NPY was found to have hypnotic properties, possibly acting as a physiological antagonist of corticotropin-releasing hormone (CRH). In conclusion, NPY participates in sleep regulation in humans, particularly in the timing of sleep onset and may as such play a role in the integration of sleep regulation, food intake and metabolism.
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Interactions between NPY and CRF in the amygdala to regulate emotionality.Neuropeptides. 2004 Aug;38(4):225-34. doi: 10.1016/j.npep.2004.05.006. Neuropeptides. 2004. PMID: 15337374 Review.
-
A possible role of neuropeptide Y in depression and stress.Brain Res. 2010 Feb 16;1314:194-205. doi: 10.1016/j.brainres.2009.09.077. Epub 2009 Sep 25. Brain Res. 2010. PMID: 19782662 Review.
-
Role of hypothalamic neuropeptide Y in feeding and obesity.Neuropeptides. 1999 Oct;33(5):329-38. doi: 10.1054/npep.1999.0057. Neuropeptides. 1999. PMID: 10657510 Review.
-
Roles of corticotropin-releasing factor, neuropeptide Y and corticosterone in the regulation of food intake in Xenopus laevis.J Neuroendocrinol. 2004 Mar;16(3):279-88. doi: 10.1111/j.0953-8194.2004.01168.x. J Neuroendocrinol. 2004. PMID: 15049859
-
Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y.Proc Assoc Am Physicians. 1998 May-Jun;110(3):171-82. Proc Assoc Am Physicians. 1998. PMID: 9625524
Cited by
-
A deleterious variant of INTS1 leads to disrupted sleep-wake cycles.Dis Model Mech. 2024 Aug 1;17(8):dmm050746. doi: 10.1242/dmm.050746. Epub 2024 Aug 27. Dis Model Mech. 2024. PMID: 39189071 Free PMC article.
-
In cerebrovascular circadian rhythms, EETs keep the beat. Focus on "Rhythmic expression of cytochrome P450 epoxygenases CYP4x1 and CYP2c11 in the rat brain and vasculature".Am J Physiol Cell Physiol. 2014 Dec 1;307(11):C986-8. doi: 10.1152/ajpcell.00327.2014. Epub 2014 Oct 1. Am J Physiol Cell Physiol. 2014. PMID: 25273881 Free PMC article. No abstract available.
-
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.Neuropsychopharmacology. 2020 Jan;45(1):141-165. doi: 10.1038/s41386-019-0446-0. Epub 2019 Jun 24. Neuropsychopharmacology. 2020. PMID: 31234199 Free PMC article. Review.
-
Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response.Curr Neuropharmacol. 2018;16(4):371-387. doi: 10.2174/1570159X15666170720092442. Curr Neuropharmacol. 2018. PMID: 28730966 Free PMC article. Review.
-
Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial.BMC Anesthesiol. 2023 May 26;23(1):182. doi: 10.1186/s12871-023-02092-2. BMC Anesthesiol. 2023. PMID: 37237331 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous